NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 138 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR Patient Guide on Immunotherapy Side Effects and Their Management Now Available... April 29, 2026 How Joining a Clinical Trial Helped Me Find Hope While Living... December 5, 2023 Adjuvant Atezolizumab Plus Bevacizumab Improves RFS Among Patients at High Risk... November 16, 2023 Tesco is making it even easier to support life-saving research February 3, 2023 Load more HOT NEWS 9/11 Firefighter Dies Of Cancer From Working At Ground Zero Coverage for Breast Cancer Genetic Marker Testing is Still Being Denied... One year on: How has COVID-19 affected cancer services? Getting through the Holidays-With a Little Help From Oncolink
